Up to 8% of cancer patients refuse chemotherapy because they don’t want to lose their hair. Of course, hair loss can cause immense damage to a person’s self-esteem — but it can also strip ...

Researchers from the University of Colorado Cancer Center have solved a cellular mystery that may lead to better therapies ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

Brain cancer remains one of medicine's most formidable challenges, requiring sophisticated treatment approaches tailored to each patient's specific situation.

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National ...

Vermont Business Magazine Creativity and community will be in high fashion this April, when dozens of oncology and infusion ...

New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...